A Study of Intravenous Perampanel in Japanese Participants With Epilepsy

Summary

The purpose of the study is to evaluate the safety and tolerability of perampanel administered as a 30-minute intravenous infusion after switching from oral tablets (8 to 12 milligrams per day \[mg/day\]) as an adjunctive therapy in participants with epilepsy with partial onset seizures (POS) (including secondarily generalized seizures) or primary generalized tonic-clonic (PGTC) seizures.

Timeline

Start

2018-11-27

Primary completion

2019-12-10

Completion

2019-12-10

Drugs

Indications